Status: Recruiting
Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder
The purpose of this study is to determine the safety and efficacy of HB-1, versus placebo in male and female adult patients aged 18 to 65 years, inclusive, with Post-Traumatic Stress Disorder (PTSD).
Participants needed: 200
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: HB BioTech, LLCUpdated: Jun 4, 2026Locations: 15
Eligibility criteria
Male or female aged 18 to 65 years old, inclusive, at the time of informed conse... [+10]
Any ongoing concomitant disease, condition, or treatment that could interfere wi... [+14]